Fraud upends oral cancer field, casting doubt on prevention trial

Science

Volumn 311, Issue 5760, 2006, Pages 448-449

  Couzin, Jennifer ^a   Schirber, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHARMACEUTICAL INDUSTRY;

ANEUPLOIDY; CANCER PREVENTION; CANCER RESEARCH; FORGERY; MOUTH CANCER; NOTE; PRIORITY JOURNAL; SCIENTIFIC MISCONDUCT; SMOKING; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; DISEASE PREDISPOSITION; GENETICS; HUMAN; MOUTH DISEASE; MOUTH TUMOR; PATHOLOGY; RISK FACTOR;

CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZOLE DERIVATIVE; SULFONAMIDE;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ANEUPLOIDY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; DISEASE SUSCEPTIBILITY; HUMANS; MOUTH DISEASES; MOUTH NEOPLASMS; PYRAZOLES; RISK FACTORS; SCIENTIFIC MISCONDUCT; SULFONAMIDES;

EID: 31544434289     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: None     Document Type: Note

References (0)